N Engl J Med 2011 Dec 29
A phase 3 trial of bevacizumab in ovarian cancer.   

Related Questions

With the recent publication of GOG252 - does this change your management for patients with ovarian cancer who undergo primary surgery who have an opti...

How (if at all) does this change your counseling and willingness to add bevacizumab to a regimen?

Patient is currently cycle 5/6 of carboplatin/taxol and tolerating well, has received no bevacizumab.